Quantum Genomics announces that Stéphane Cohen, a pharmacist and ESSEC graduate, is joining the team as Director of Global Operations. He will be responsible for liaising with current and future international partner laboratories, implementing the operational strategy in line with good governance, and preparing the market launch of firibastat. Stéphane Cohen has held operational management and senior leadership positions involving a dozen successful market launches of new treatments in major pharmaceutical companies, particularly at Bayer and Pfizer for eighteen years.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1292 EUR | +1.89% | +9.86% | +21.89% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.89% | 4.81M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- ALQGC Stock
- News Quantum Genomics
- Stéphane Cohen Joins Quantum Genomics as Director of Global Operations